Elena L. H.
- Country
- Spain
- Department
- Hematology Unit
Research Overview
Data & Insights
Has run more than one trial at 0 of 99 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in the treatment of multiple myeloma, with particular emphasis on addressing relapsed and refractory cases of this hematologic malignancy.
- Blood Cancer Treatment
- Multiple Myeloma Management
- Refractory Disease Approaches
The investigator explores novel therapeutic strategies for patients who have received prior targeted therapies.
Immunotherapy
The investigator focuses on innovative immunotherapeutic approaches in blood cancer treatment, including the evaluation of monoclonal antibody therapies and their combinations.
- Targeted Therapy Development
- Antibody-Based Treatments
- Combination Therapy Strategies
Their work encompasses the investigation of various therapeutic combinations to optimize treatment outcomes.
Treatment Resistance
The investigator specializes in developing treatment strategies for therapy-resistant blood cancers, particularly focusing on patients who have undergone previous treatments.
- Drug Resistance Mechanisms
- Alternative Treatment Pathways
- Sequential Therapy Approaches
Their research addresses the challenges of treating patients who have developed resistance to standard therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.